Lactose Anhydrous

Overview
Posts
Linked Effects
Linked Biomarkers
Users

About Lactose Anhydrous

Lactose Anhydrous

Overview

Lactose anhydrous is a disaccharide composed of glucose and galactose, derived from the whey fraction of bovine milk, with the molecular formula C12H22O11 and minimal water content (less than 0.5%)123. Unlike the more common α-lactose monohydrate, it primarily consists of β-lactose crystals, offering higher solubility and faster dissolution rates1. Primarily used as a pharmaceutical excipient rather than a nutritional supplement, it serves as a filler, binder, and diluent in tablets, capsules, and dry powder inhalers24. Historically, lactose has been extracted from milk whey since the 17th century for food and medicinal uses, with anhydrous forms developed for modern pharmaceutical applications requiring moisture-sensitive stability17. Its sweet taste and excellent flowability make it ideal for direct compression tableting25.

Forms and Variations

Lactose anhydrous is available as a fine, free-flowing, white to creamy white powder, often produced via roll-drying of lactose solutions on heated drums, resulting in agglomerated crystals of primarily β-anhydrous lactose with some α-form25. Variations include standard anhydrous lactose for direct compression and specialized grades like micronized forms for inhalation products4. It differs from α-lactose monohydrate (hydrated, stable under moisture) by its higher solubility (40g/100ml at 25°C) but greater sensitivity to humidity, which can cause conversion to monohydrate12. Choose anhydrous for moisture-sensitive drugs or rapid dissolution needs, while monohydrate suits wet granulation; β-form preferred for better compactability and flow14.

Dosage and Administration

As a pharmaceutical excipient, lactose anhydrous has no standard nutritional dosage; amounts vary by formulation, typically 20-80% of tablet weight as filler24. For direct compression, it is blended dry with active ingredients and compressed into tablets without additional water5. Best practices include storing in dry conditions to prevent moisture absorption and conversion to monohydrate, using desiccants if needed1. Take orally as part of tablets or capsules; for inhalation, use micronized grades. Individuals with lactose intolerance should avoid products containing it due to potential digestive issues3. Always follow product-specific instructions from manufacturers.

Scientific Research and Mechanism of Action

Research on lactose anhydrous focuses on its pharmaceutical utility rather than therapeutic effects. It acts as an inert diluent and binder due to its compactability from β-crystal structure and amorphous content, enabling strong tablets via direct compression245. Higher β-anomer content enhances solubility (faster dissolution than monohydrate) via distinct crystal lattice allowing quicker water penetration1. Studies show it remains stable under dry storage but converts to α-monohydrate in humid conditions, affecting flow and stability1. In the body, undigested lactose in intolerant individuals ferments in the gut, producing gas; otherwise, it hydrolyzes via lactase to glucose and galactose for energy37. Current research emphasizes optimized grades for inhalation and controlled-release formulations4.

Benefits and Potential Uses

Lactose anhydrous excels as a versatile excipient in oral solid dosage forms, providing excellent flowability, compressibility, and rapid disintegration for quick drug release25. Ideal for direct compression tableting, reducing processing steps and costs; suitable for moisture-sensitive APIs like certain antibiotics or enzymes14. In inhalation products, micronized anhydrous lactose acts as a carrier for dry powder inhalers, improving aerosolization4. Its high solubility supports fast-dissolving tablets; non-hygroscopic nature ensures shelf stability2. Potential uses include capsules, sachets, and granulation; nutritionally, small amounts provide energy as a carbohydrate source in formulas, though primarily excipient, not active nutrient3. Proven in pharmaceuticals for consistent drug delivery without altering bioavailability.

Side Effects and Risks

For most people, lactose anhydrous in medicinal doses causes no direct side effects as an excipient6. However, in lactose-intolerant individuals (lacking lactase enzyme), it may cause bloating, gas, diarrhea, or abdominal pain due to bacterial fermentation in the colon37. Rare allergic reactions to milk proteins if contaminated. Dust form poses inhalation risk during manufacturing, potentially explosive in air6. Reactive with strong oxidizers; decomposes at 203.5°C6. Contraindicated for those with galactosemia (genetic inability to metabolize galactose)3. Infants, elderly, or those with IBS should use caution; monitor for GI upset in sensitive groups.

Interactions and Precautions

No significant drug interactions as an excipient, but in intolerant users, it may affect absorption of co-administered drugs due to osmotic diarrhea3. Avoid with moisture-sensitive medications during formulation to prevent stability issues1. Precautions for lactose-intolerant, dairy-allergic, or galactosemic patients; test tolerance if high doses7. Pregnant or lactating women: safe in small excipient amounts, but monitor for intolerance. Pre-surgical: no specific issues, but inform if intolerant. Manufacturing: avoid dust formation and oxidizers6. Consult physician for personalized advice, especially with GI conditions.

Impact on Biomarkers

Lactose anhydrous minimally impacts biomarkers in tolerant individuals, providing glucose/galactose for blood sugar if digested3. In intolerant people, elevates breath hydrogen/methane (lactose intolerance test) and stool osmotic gap due to malabsorption7. May transiently raise blood glucose in large amounts. No direct effects on lipids, liver enzymes, or inflammatory markers; stable in blood tests as excipient6.

Overdose and Toxicity

Low toxicity; LD50 not established, but excessive intake in intolerant individuals causes severe osmotic diarrhea, dehydration, electrolyte imbalance3. No established upper limit for excipient use; nutritional safe intake ~12-13g/day for adults to avoid symptoms7. Symptoms: nausea, cramps, vomiting at high doses. Treat supportively; toxicity rare unless contaminated. Store dry to avoid degradation16.

References
  1. AUCO Industry. What is the difference between lactose and anhydrous lactose. https://www.aucoindustry.com/What-is-the-difference-between-lactose-and-anhydrous-lactose-id45648136.html
  2. Pharma Excipients. Anhydrous Lactose Family by Kerry. https://www.pharmaexcipients.com/news/anhydrous-lactose-kerry/
  3. PubChem. Lactose, anhydrous. https://pubchem.ncbi.nlm.nih.gov/compound/Lactose_-anhydrous
  4. Armor Pharma. Exploring the Versatility of Pharmaceutical Lactose. https://www.armor-pharma.com/pharmaceutical-lactose-versatility/
  5. Drug-Dev.com. Lactose in Pharmaceutical Applications. https://drug-dev.com/lactose-in-pharmaceutical-applications/
  6. Spectrum Chemical. LA103, Anhydrous Lactose, NF - Scientific Documentation. https://www.spectrumchemical.com/media/sd/LA103_SD.pdf
  7. Wikipedia. Lactose. https://en.wikipedia.org/wiki/Lactose

Disclaimer

The information provided in this document is for educational purposes only and does not constitute medical advice. It is essential to consult with a qualified healthcare professional for any health concerns or before making any decisions related to your health or treatment.

Loading...

Loading supplement interactions...

Loading...

Loading posts...

Loading...

Loading linked effects...

Loading...

Loading linked biomarkers...

Loading...

Loading users...

Loading...

Walkthrough

Loading...

Description

Step 1 of 5
Walkthrough Step